Projects funded by the NCN

Nanostructured materials as a platform for synthesis and delivery of therapeutical substances

Call: OPUS 8 , Panel: ST5

Principal investigator: prof. Wiesław Roth

Uniwersytet Jagielloński, Wydział Chemii

Engineering of intelligent inhalable therapeutics with the capacity for guided accumulation and triggered release of act...

Call: HARMONIA 6 , Panel: ST5

Principal investigator: prof. Elżbieta Pamuła

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

Genetic and environmental factors as predictors of individual therapeutical response in Polish psoriatic patients

Call: OPUS 6 , Panel: NZ5

Principal investigator: prof. Joanna Narbutt

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Endogenous enkephalinase inhibitors and their novel synthetic analogs as potential new therapeutics for the treatment of...

Call: OPUS 6 , Panel: NZ7

Principal investigator: dr hab. Jakub Fichna

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Interactions between biologically active phytocompounds present in the fodder and selected therapeuticals used in the th...

Call: SONATA 3 , Panel: NZ9

Principal investigator: dr hab. Marta Mendel

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease

Call: M-ERA.NET 3 Call 2023 , Panel: NZ5

Principal investigator: dr hab. Anna Haduch

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

Call: SONATA BIS 13 , Panel: NZ7

Principal investigator: dr hab. Miłosz Ruszkowski

Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

Prioritizing diagnostics and therapeutics of human prion diseases through integrative omics

Call: JPND Call 2023 , Panel: NZ2

Principal investigator: prof. Beata Sikorska

Uniwersytet Medyczny w Łodzi

Designing Active Inhibitors of SARS-CoV-2 Methyltransferases

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Alex Matsuda

Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

Call: POLONEZ BIS 3 , Panel: NZ5

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

Call: OPUS 22 , Panel: NZ7

Principal investigator: dr hab. Anna Wardowska

Gdański Uniwersytet Medyczny, Wydział Lekarski

Development of tools for the rational design of peptide therapeutics

Call: OPUS 20 , Panel: NZ2

Principal investigator: dr hab. Sebastian Kmiecik

Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

Modulation of immune cells activity in the tumor microenvironment by oligonucleotide therapeutics delivered by silk nano...

Call: OPUS 19 , Panel: NZ6

Principal investigator: dr hab. Hanna Dams-Kozłowska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Improving the healing potential of therapeutic proteins by planned, specific modifiactions on the example of bacteriolyt...

Call: PRELUDIUM 18 , Panel: NZ6

Principal investigator: Marek Harhala

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Curcuminoid-polyphenol conjugates as potential therapeutics for urinary system cancer treatment

Call: OPUS 18 , Panel: NZ7

Principal investigator: prof. Tomasz Gośliński

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Oligomer-Focused Screening and Individualized Therapeutics to target Neurodegenerative Disorders

Call: JPND2019 , Panel: NZ1

Principal investigator: dr Piotr Hańczyc

Uniwersytet Warszawski

Gold and silver nanoparticles as carriers for delivery of 5' end mRNA cap analogues with potential therapeutical applica...

Call: OPUS 16 , Panel: ST5

Principal investigator: dr hab. Marzena Jankowska-Anyszka

Uniwersytet Warszawski, Wydział Chemii

New usnic acid derivatives as anticancer therapeutics

Call: HARMONIA 9 , Panel: NZ7

Principal investigator: prof. Anna Herman-Antosiewicz

Uniwersytet Gdański, Wydział Biologii

The role of insulin signaling in melanoma maintenance and response to targeted therapeutics

Call: PRELUDIUM 13 , Panel: NZ3

Principal investigator: Marta Osrodek

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Sphingosine kinase 1 as a modulator of vascular function - mechanisms and therapeutical opportunities

Call: SONATA BIS 6 , Panel: NZ4

Principal investigator: dr hab. Mateusz Siedliński

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum, Wydział Lekarski